NCT03697291

Brief Summary

Peripherally Inserted Central Catheter (PICC) is considered a central venous line placement (CVL) which mandates the confirmation of the tip's location. At present, most CVL's position are confirmed by radiographic method either by in-procedure fluoroscopy or post-insertion x-ray. For CVLs placed from upper body (from internal jugular vein, subclavian veins or upper arm veins), the intracavitary electrocardiogram (iECG) can also be used. Intracavitary ECG are proven effective for tip confirmation and provide some benefits i.e. lower cost, decrease exposure to harmful radiation for care providers and also the patients, require less personals and equipments, provide real-time confirmation as comparable to fluoroscopy, etc. There are several devices and makes of iECG apparatus but B.Braun-Certodyn® remains the only available system in our institution. The limitation is the availability of the Certodyn devices on each locations where CVL will be placed i.e. operating theater, intensive care unit, bedside placement, radiology suite, etc. Since the connecting wire is only supplied in the certain CVL kits under B.Braun brand, this has rendered iECG for other types or makes of CVL or PICC line become even more difficult. Self-invented connector wire for iECG (PS wire) has been made and used effectively in the past few years at Siriraj hospital. The patent registration is underway and the author seek to compare this PS wire against the commercial Certodyn system.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 5, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2019

Completed
Last Updated

October 9, 2018

Status Verified

October 1, 2018

Enrollment Period

11 months

First QC Date

October 1, 2018

Last Update Submit

October 4, 2018

Conditions

Keywords

Self invented iECG wirePS wireCertodynintracavitary ECGPICC linegiant P wave

Outcome Measures

Primary Outcomes (1)

  • Signal noise ratio

    Measuring the segment of ECG noise (if exists) in millimeters compare to the total ECG segment. Compare this signal noise ratio between the baseline surface ECG, the self-invented wire derived iECG and the Certodyn derived iECG.

    10 minutes

Secondary Outcomes (1)

  • The amplitude of giant P Wave

    5 minutes

Study Arms (2)

PS wire

EXPERIMENTAL

self-invented iECG wire

Device: PS wire

Certodyn

ACTIVE COMPARATOR

Commercially available iECG system - Certodyn

Device: PS wire

Interventions

PS wireDEVICE

The wiring connection used to convey ECG signal from inside the body

Also known as: Self-invented iECG wire
CertodynPS wire

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient age 18 years and above.
  • Requires PICC line insertion from upper torso.

You may not qualify if:

  • Children younger than 18 years.
  • Patient with atrial fibrillation or other rhythms not generated from intrinsic SA node i.e. pacer, atrial fibrillation, etc.
  • Unstable hemodynamic.
  • Patient with history arrhythmias.
  • Patient with HR \> 120 bpm.
  • Patients with hypercoagulable state.
  • Allergy to heparin.
  • Patients with known heparin induced thrombocytopenia.
  • Patients with known Creutzfeldt-Jakob Disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Siriraj hospital, Mahidol university

Bangkok Noi, Bangkok, 10700, Thailand

RECRUITING

Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital

Bangkok, 10700, Thailand

RECRUITING

Related Publications (1)

  • 1. Oster, D.D. "Improving ECG trace quality." Biomedical Instrumentation & Technology, 2000; 34: 219-222. 2. Corsten SA, van Dijk B, Bakker NC, de Lange JJ, Scheffer GJ. Central venous catheter placement using the ECG-guided Cavafix-Certodyn SD catheter. J Clin Anesth. 1994; 6(6): 469-72. 3. Pittiruti M, La Greca A, Scoppettuolo G. The electrocardiographic method for positioning the tip of central venous catheters. J Vasc Access. 2011; 12(4): 280-91. 4. Pittiruti M, Bertollo D, Briglia E, Buononato M, Capozzoli G, De Simone L, La Greca A, Pelagatti C, Sette P. The intracavitory ECG method for positioning the tip of central venous catheters: results of an italian multicenter study. J Vasc Access. 2012; 13(3):357-65. 5. Wang G, Guo L, Jiang B, Huang M, Zhang J, Qin Y. Factors Influencing Intracavitory Electrocardiographic P-Wave Changes during Central Venous Catheter Placement. PLoS One. 201510(4):e0124846. 6. Yuan L, Li R, Meng A, Feng Y, Wu X, Yang Y, et al. Superior success rate of intracavitory electrocardiogram guidance for peripherally inserted central catheter placement in patients with cancer: A randomized open-label controlled multi center study. PLoO One. 2017; 12(3):e0171630.

    BACKGROUND

Study Officials

  • Prasert Sawasdiwipachai, MD

    Anesthesiology department Siriraj hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Prasert Sawasdiwipachai, MD

CONTACT

Vithaya Chaithiraphan, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
unlabeled ECG print
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Single center, prospective, cross over study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 1, 2018

First Posted

October 5, 2018

Study Start

August 1, 2018

Primary Completion

June 30, 2019

Study Completion

October 31, 2019

Last Updated

October 9, 2018

Record last verified: 2018-10

Locations